Evidence mapPaperPMID 34675928Full record

ArticleFrontiers in immunology2021

The Partitioning of Newly Assimilated Linoleic and α-Linolenic Acids Between Synthesis of Longer-Chain Polyunsaturated Fatty Acids and Hydroxyoctadecaenoic Acids Is a Putative Branch Point in T-Cell Essential Fatty Acid Metabolism.

Johanna von Gerichten, Annette L West, Nicola A Irvine, Elizabeth A Miles, Philip C Calder, Karen A Lillycrop, Barbara A Fielding, Graham C Burdge

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07065383 (Intramyocellular Lipid Compartments After Glucagon-like Peptide 1 Receptor Agonist Therapy in Type 2 Diabetes - Rebalancing the Fat Content of the Heart and Muscles), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07065383 narecruitingstarted 2025, after this paper: background citation

Intramyocellular Lipid Compartments After Glucagon-like Peptide 1 Receptor Agonist Therapy in Type 2 Diabetes - Rebalancing the Fat Content of the Heart and Muscles

Ran2025Enrolled60Registered outcomes2Posted comparisons0ConditionsDiabetes Mellitus Type 2ArmsSemaglutide administration plus dietary counselling and physical activity encouragement, Semaglutide plus a personalised and supervised program of resistance and endurance training
Open the trial in the graph
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Oxylipin secretion by human CD3Frontiers in immunology · 2023
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Johanna von GerichtenDepartment of Nutritional Sciences, Faculty of Health and Medical Sciences, University of Surrey, Surrey, United Kingdom.
Annette L WestSchool of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Nicola A IrvineSchool of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Elizabeth A MilesSchool of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Philip C CalderSchool of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
Karen A LillycropCentre for Biological Sciences, Faculty of Natural and Environmental Sciences, University of Southampton, Southampton, United Kingdom.
Barbara A FieldingDepartment of Nutritional Sciences, Faculty of Health and Medical Sciences, University of Surrey, Surrey, United Kingdom.
Graham C BurdgeSchool of Human Development and Health, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.
University of Southampton · GBUniversity of Surrey · GB

Funding

Biotechnology and Biological Sciences Research Council BB/S005358/1Biotechnology and Biological Sciences Research Council BB/S00548X/1
6 · The paper itself

Abstract

Longer-chain polyunsaturated fatty acids (LCPUFAs) ≥20 carbons long are required for leukocyte function. These can be obtained from the diet, but there is some evidence that leukocytes can convert essential fatty acids (EFAs) into LCPUFAs. We used stable isotope tracers to investigate LCPUFA biosynthesis and the effect of different EFA substrate ratios in human T lymphocytes. CD3

Indexed as

AdolescentAdultalpha-Linolenic AcidCells, CulturedFatty Acid DesaturasesFatty Acid ElongasesFatty Acids, EssentialFatty Acids, UnsaturatedFemaleGas Chromatography-Mass SpectrometryHumansLinoleic AcidLipid MetabolismLymphocyte ActivationMaleT-Lymphocytesalpha-Linolenic AcidELOVL5 protein, humanFADS2 protein, humanFatty Acid DesaturasesFatty Acid ElongasesFatty Acids, EssentialFatty Acids, Unsaturatedhydroxyoctadecadienoic acidLinoleic AciddesaturaseelongaseELOVL5FADS2omega-3 and omega-6 polyunsaturated fatty acidsoxylipinstable isotopeT lymphocyte

Identifiers

PMID34675928
PMCPMC8523940
OpenAlexW3203211868

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.